Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05124457 · ClinicalTrials.gov registry record · Phase 2
DETERMINE: Detemir vs NPH
A Phase 2 study of Diabetes Mellitus, Type 2 and Gestational Diabetes, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 336
- Enrollment target
- 1
- Study location
NCT05124457 is a Phase 2 study of Diabetes Mellitus, Type 2 and Gestational Diabetes that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 336 participants, below the 4,484-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05124457, a Phase 2 study of Diabetes Mellitus, Type 2 and Gestational Diabetes, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 336 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to compare rates of neonatal hypoglycemia with maternal NPH vs determir use.
Conditions Studied
Interventions
- DRUG Insulin Detemir
- DRUG Insulin NPH
Study Locations (1)
California
- University of California, Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 336 participants |
| Start Date | 2022-02-01 |
| Est. Completion | 2025-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05124457
The ClinicalTrials.gov registry entry for NCT05124457 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 336 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,484-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (93% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 2 interventions - of which Insulin Detemir is the first listed.
NCT05124457 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05124457 about?
NCT05124457 is a clinical study titled "DETERMINE: Detemir vs NPH". The purpose of the study is to compare rates of neonatal hypoglycemia with maternal NPH vs determir use.
What is the current status of trial NCT05124457?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 336 participants. The study started on 2022-02-01. Estimated completion is 2025-06.
What conditions does trial NCT05124457 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Gestational Diabetes.
What interventions are being tested in trial NCT05124457?
The interventions under investigation include: Insulin Detemir (DRUG), Insulin NPH (DRUG).
Who is sponsoring clinical trial NCT05124457?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05124457 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MANAGe-DM: Novel Nurse Case Management to Improve Diabetes Outcomes in Formerly Incarcerated Black Men
RECRUITING · Phase 2
-
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
RECRUITING · Phase 2
-
A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin
RECRUITING · Phase 2
-
A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy
ACTIVE NOT RECRUITING · Phase 2
-
Addressing Basic Needs to Improve Diabetes Outcomes in Medicaid Beneficiaries
ACTIVE NOT RECRUITING · Phase 2
-
Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes
ACTIVE NOT RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.